v3.26.3
Stockholders' Equity
9 Months Ended
Sep. 30, 2026
Stockholders' Equity  
Stockholders' Equity

NOTE 7 - Stockholders’ Equity

Common Stock

The holders of the Company’s common stock are entitled to one vote per share with respect to all matters required by law to be submitted to stockholders. The holders of common stock have the sole right to vote. The common stock does not have any cumulative voting, pre-emptive, subscription or conversion rights. Election of directors requires the affirmative vote of a plurality of shares represented at a meeting of the Company’s stockholders, and other general stockholder actions (other than an amendment to our certificate of incorporation) require the affirmative vote of a majority of shares represented at a meeting in which a quorum is present. The outstanding shares of common stock are validly issued, fully paid and non-assessable.

On May 13, 2025, the stockholders of the Company voted to increase the number of shares of common stock reserved for issuance pursuant to awards under the Company’s 2022 Stock Incentive Plan from 6,250,000 to 10,750,000. As of September 30, 2026, a total of 3,872,085 shares of common stock remain available for future grants under the 2022 Stock Incentive Plan.

On February 9, 2026, the Company announced the successful closing of a public offering, whereby we raised gross proceeds of approximately $76.4 million by issuing 12,336,000 shares of our common stock at a price of $6.08 per share and issuing 225,000 shares of our common stock by the exercise of an option offered to the book-running managers and co-managers (the “Option”) at a price of $6.08 per share. The Company incurred a total of approximately $4.7 million of share issuance costs pursuant to the public offering and exercise of the Option, which were recorded as a reduction to additional paid-in capital.

NOTE 7 - Stockholders’ Equity (continued)

On March 25, 2025, the Company announced a public offering through which the Company raised gross proceeds of approximately $35.1 million by issuing 12,400,000 shares of our common stock at a price of $2.83 per share. The Company incurred a total of approximately $2.3 million of share issuance costs pursuant to the public offering and recorded the share issuance costs as a reduction to additional paid-in capital.

On November 13, 2025, Dakota Gold entered into an Amended and Restated Equity Distribution Agreement (the “Amended and Restated EDM”) with BMO Capital Markets Corp., Canaccord Genuity LLC and H.C. Wainwright & Co., LLC (collectively, the “Sales Agents”). Under the terms of the Amended and Restated EDM, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $50.0 million from time to time through any of the Sales Agents. During the nine months ended September 30, 2026 and 2025, the Company utilized the ATM Program to raise net proceeds of approximately $3.5 million and $7.3 million, respectively, by issuing 586,749 and 2,548,713 shares of common stock, respectively.

On October 20, 2023, OMF Fund IV SPV C LLC, an entity managed by Orion Mine Finance (collectively, “Orion”), was granted a right to match the terms of future financings of the Company (the “Matching Right”). As of September 30, 2026, the Company has raised approximately $138.4 million in exempt gross proceeds, and no proceeds subject to the Matching Right. As of September 30, 2026, the Company has approximately $61.6 million in exemptions from the Matching Right remaining.

Stock-based Compensation

Stock-based compensation expense is included in exploration as well as general and administrative expenses, based upon the primary activities of the grantees. The Company recognized stock-based compensation expense as follows in the accompanying consolidated statement of operations:

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended September 30, 

​

Nine months ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

​

​

$

​

$

​

$

​

$

RSUs

​

515,452

 

420,401

​

1,258,931

 

1,111,761

PSUs

​

25,985

 

111,502

​

30,013

 

252,945

Stock options

​

213,748

 

248,520

​

743,165

 

285,734

Allocated to general and administrative expense

​

755,185

 

780,423

​

2,032,109

 

1,650,440

​

​

​

​

​

​

​

​

​

RSUs

​

172,898

 

128,282

​

432,707

 

424,676

PSUs

​

—

 

30,387

​

(47,094)

 

141,762

Stock options

​

25,308

 

69,986

​

75,608

 

156,833

Allocated to exploration expense

​

198,206

 

228,655

​

461,221

 

723,271

Total stock-based compensation expense

​

953,391

 

1,009,078

​

2,493,330

 

2,373,711

​

During the nine months ended September 30, 2026, the Company granted the following stock-based compensation awards:

​

​

​

​

​

​

​

  ​ ​ ​

Number of

  ​ ​ ​

Weighted

​

​

equity

​

average fair

​

​

awards

​

value

​

​

#

​

$

RSUs

 

676,706

​

5.02

Stock options

 

218,026

​

1.80

Total equity awards granted

 

894,732

​

—

​

NOTE 7 - Stockholders’ Equity (continued)

As of September 30, 2026, unrecognized compensation expense and weighted-average vesting period for each of the Company’s stock-based compensation awards were as follows:

​

​

​

​

​

​

​

​

Unrecognized

​

Weighted-

​

​

compensation

​

average

​

​

expense

​

vesting period

​

  ​ ​ ​

$

  ​ ​ ​

Years

RSUs

​

3,149,155

​

1.47

PSUs

​

45,907

​

0.79

Stock options

​

952,070

​

1.42

​

​

4,147,132

​

1.42

​

Warrants

​

As of September 30, 2026 and December 31, 2025, the Company had nil and 5,582,545 warrants outstanding, respectively. During the nine months ended September 30, 2026 and 2025, 5,239,821 and 1,423,153 warrants were exercised, respectively, and 342,724 and nil warrants expired unexercised, respectively.